Yet, efficient treatment for cardiac ischemia/reperfusion injury is still missing in clinics. ATP release through Pannexin1 (PANX1) channels facilitates recruitment of leukocytes to the injured ...
Rochester, MN - Starting a 72-hour infusion of nesiritide (Natrecor, Scios/Johnson & Johnson) after successful MI reperfusion therapy apparently suppressed aldosterone levels and may have had a ...
When reading the ECG of a patient presenting with cardiopulmonary complaints, the most important duty of acute care clinicians is to determine whether there is evidence of an acute coronary occlusion ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The drug met primary safety and efficacy outcomes, with full results to be presented at the AHA Scientific Sessions.
A large new study found that beta blockers did not provide clear benefits for heart attack patients whose hearts were still ...
Alternative model systems to study ischemia-reperfusion are needed to support a wide range of disease-related investigations in the life sciences. Ischemia and reperfusion are relevant to many disease ...
Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke. As many as one in four people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback